Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

European School of Haematology (ESH) meeting: International Conference on Acute Lymphoblastic Leukaemia 2019 (ICALL) /
T cell development and T cell leukaemia

17th - 19th May 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.05.19
Views: 777
Rating:

Prof Hans-Reimer Rodewald - Universitätsklinikum Heidelberg, Heidelberg, Germany

Prof Hans-Reimer Rodewald talks to ecancer at the European School of Haematology (ESH) meeting: International Conference on Acute Lymphoblastic Leukaemia about the development of T cells and T cell leukaemia.

He describes the concept of autonomous T cells and their transformation to T cell lymphoblastic leukaemia.

Prof Rodewald also outlines the therapeutic opportunities for this disease and highlights the idea of "cell competition" and how this could be a possible target.

He also describes the next steps for this research, which include identifying additional mutations associated with this disease to identify cells that can undergo cellular transformation.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation